The Beauty Health Company (NASDAQ:SKIN) Shares Sold by Jacobs Levy Equity Management Inc.

Jacobs Levy Equity Management Inc. lowered its stake in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) by 24.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,889,700 shares of the company's stock after selling 609,952 shares during the quarter. Jacobs Levy Equity Management Inc. owned 1.52% of Beauty Health worth $3,005,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of SKIN. SG Americas Securities LLC grew its stake in Beauty Health by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 35,290 shares of the company's stock worth $56,000 after purchasing an additional 9,749 shares in the last quarter. Barclays PLC boosted its stake in shares of Beauty Health by 11.1% in the 4th quarter. Barclays PLC now owns 117,920 shares of the company's stock valued at $187,000 after buying an additional 11,817 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Beauty Health during the fourth quarter worth about $25,000. Price T Rowe Associates Inc. MD grew its position in shares of Beauty Health by 19.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 114,147 shares of the company's stock worth $182,000 after buying an additional 18,400 shares in the last quarter. Finally, Newman Dignan & Sheerar Inc. increased its stake in shares of Beauty Health by 39.1% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 71,144 shares of the company's stock worth $113,000 after buying an additional 20,000 shares during the period. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Beauty Health Stock Performance

Shares of Beauty Health stock traded down $0.10 during trading on Monday, reaching $1.64. The company's stock had a trading volume of 494,511 shares, compared to its average volume of 1,063,401. The company has a 50-day moving average price of $1.21 and a two-hundred day moving average price of $1.44. The Beauty Health Company has a fifty-two week low of $0.78 and a fifty-two week high of $2.76. The firm has a market cap of $205.40 million, a PE ratio of -3.90 and a beta of 0.88. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23.

Beauty Health (NASDAQ:SKIN - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.05. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. The business had revenue of $69.60 million during the quarter, compared to analysts' expectations of $63.88 million. On average, analysts forecast that The Beauty Health Company will post -0.25 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group dropped their price objective on shares of Beauty Health from $1.50 to $1.25 and set a "hold" rating on the stock in a research report on Monday, May 5th.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.